drugset / Trial / NCT00688922

Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study

NCT00688922

Phase 4 Unknown 400 enrolled Osaka Acute Coronary Insufficiency Study Group
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the Study is to determine whether early treatment with pravastatin can reduce adverse cardiac events in patients with acute myocardial infarction and minimally to mildly elevated serum Low Density Lipoprotein -Cholesterol (LDL-C) levels.

Timeline

Start
2008-07
Primary completion
2010-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pravastatin Small molecule 10 mg